Home > PJ > News / Daily News

Return to PJ Online Home Page

The Pharmaceutical Journal Vol 267 No 7173 p667-671
10 November 2001


News summary

News in brief

Encourage immunisation for Haj now A new campaign highlights the need for pilgrims going to Mecca, Saudi Arabia, to the Haj in February 2002 to be immunised against meningitis...[more]

Harrow pharmacists launch heart disease screening programme Community pharmacists in Harrow, north London, have started an intervention programme aimed at screening patients with coronary heart disease using national service framework guidelines. Similar schemes for unwanted medicines and excessive prescribing have also started...[more]

Children do not eat sufficient fruit and vegetables Children's diets are seriously short in fruit and vegetables, a survey has found...[more]

NICE guidance on MS The National Institute for Clinical Excellence (NICE) published the final consultation document of its appraisal on beta-interferon and glatiramer acetate for multiple sclerosis (MS) on 2 November 2001...[more]

Questions raised over use of long-term of tamoxifen therapy for prevention esearchers have raised questions over the general use of tamoxifen as preventive therapy in healthy women at risk of breast cancer, although benefits were found for women at particularly high risk...[more]

Vitamin D reduces risk of diabetes Vitamin D supplementation in children reduces the risk of developing type 1 diabetes, reseachers say...[more]

Second wave MM pilots details Details of how to apply to be part of the second wave of medicines management pilots have been released by the National Prescribing Centre...[more]

Private finance scheme extended Private finance is to be extended into National Health Service primary care in a new way...[more]

New erectile dysfunction drug useful in diabetes Vardenafil, a treatment for erectile dysfunction, will be especially useful in the treatment of men with diabetes, according to new data...[more]

Pharmacy features again in NHS winter advice campaign Community pharmacy is again at the centre of the National Health Service's winter advice advertising campaign...[more]

Ramipril use in HOPE trial reduced new diabetes diagnoses Patients in the Heart Outcomes Prevention Evaluation (HOPE) trial who ended up taking the angiotensin converting enzyme inhibitor ramipril had a lower rate of being newly diagnosed with diabetes, according to a sub-analysis of the study...[more]

Trainee gets judicial review over failure of registration examination A pharmacy trainee who has failed the Royal Pharmaceutical Society's registration examination three times has been granted a judicial review of the Society's decision not to allow her a fourth attempt...[more]

Information, not advertising, is what consumers need Consumers need access to impartial, accurate information about medicines and not to be faced with partisan product advertising...[more]

Alpharma to colour-code packaging Alpharma is to colour-code all its generic medicines following a change in branding from Cox Pharmaceuticals...[more]

Lloyds boss goes back to shop floor Mike Ward, chief executive of Lloyds-pharmacy, recently spent a day working at the group's pharmacy at Cobham, Surrey, as part of a "back to the floor" initiative involving its senior management...[more]

Pharmology.com set to go live in January 2002 Pharmology.com, Alliance-UniChem's international pharmacy business and consumer website, is to be fully launched in Britain in January 2002...[more]

Counter attack leads to sales recovery in chemist sundries Unichem's "Counter attack" programme has reversed the shift of sales of toiletries and related products from community pharmacies to the grocery sector...[more]

Britain to fight Europe over animal medicines Britain is to fight a European Commission proposal to make all veterinary medicines for food-producing animals available only on prescription...[more]

UniChem writes down its standards Working standards agreements are to be introduced by UniChem Ltd so that its customers have a clear understanding of what they can expect the company to do...[more]

NHS Reform and Decentralisation Bill expected in Parliament soon A bill to make major changes to the structure of the National Health Service, the NHS Reform and Decentralisation Bill, is expected to be published within the next few days...[more]


NEWS IN BRIEF


Simplifying antiretroviral therapy Initiating antiretroviral therapy with four drugs and then simplifying the regimen to three drugs is effective for HIV treatment-naive patients, researchers say. Maintenance therapy with Trizivir (zidovudine, lamivudine, abacavir), after a quadruple-drug initiation phase, was found to be effective at maintaining viral loads at a low level (below 50 copies/ml) in addition to reducing the pill burden, researchers conclude. The results were presented at a European conference on HIV infection held in Athens on 29 October.


Positive results for fusion inhibitors Positive results for a new class of HIV treatment were presented at an HIV conference in Athens on 30 October. The new class, fusion inhibitors, prevent HIV from fusing with the host cell thus preventing the virus from entering and replicating there. In a 48-week trial in 41 patients with advanced disease, 56 per cent showed a sustained response to the fusion inhibitor T-20 and viral loads of less than 400 copies/ml were achieved in 39 per cent of patients.


More breast than lung cancer Breast cancer is now the most common form of cancer in the United Kingdom, overtaking lung cancer for the first time, according to the Imperial Cancer Research Fund and the Cancer Research Campaign. The decline in lung cancer rates reflects a fall in the number of smokers but the reasons for the rise in breast cancer rates over the past 30 years are unclear. Sir Paul Nurse, director general of the ICRF, says: "A number of factors may be contributing to these trends, for example, more women are having children later in life and there is an increase in obesity which is a risk factor in post-menopausal women."


Home | Journals | News | Notice-board | Search | Jobs  Classifieds | Site Map | Contact us

©The Pharmaceutical Journal